# Shortening Duration of Antiarrhythmic Medication for SVT in Infants

> **NCT04837261** · — · COMPLETED · sponsor: **Tampere University Hospital** · enrollment: 107 (actual)

## Conditions studied

- Supraventricular Tachycardia

## Interventions

- **DRUG:** Propranolol
- **DRUG:** Flecainide
- **DRUG:** Amiodarone

## Key facts

- **NCT ID:** NCT04837261
- **Lead sponsor:** Tampere University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-15
- **Primary completion:** 2024-01-31
- **Final completion:** 2024-01-31
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2025-11-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04837261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04837261, "Shortening Duration of Antiarrhythmic Medication for SVT in Infants". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04837261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*